Brief: Iterum Names Christine Coyne As Chief Commercial Officer To Lead Orlynvah™ Launch And Commercial Growth
30/06/2025 12:07
June 30 (Reuters) - Iterum Therapeutics PLC ITRM.O: ITERUM NAMES CHRISTINE COYNE AS CHIEF COMMERCIAL OFFICER TO LEAD ORLYNVAH™ LAUNCH AND COMMERCIAL GROWTH Source text: ID:nGNX25B2Ps Further company coverage: ITRM.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity